Nalaganje...
Reversible myocardial dysfunction following intraocular bevacizumab administration
Heart failure has been reported as a rare side effect of bevacizumab, a chemotherapeutic agent, used in the treatment of breast cancer. However, reversible left ventricular systolic dysfunction with a pattern similar to stress-induced cardiomyopathy has not been reported. The etiopathogenesis of str...
Shranjeno v:
| Main Authors: | , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
2013
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3758098/ https://ncbi.nlm.nih.gov/pubmed/24023476 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jcdr.2013.02.017 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|